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ABSTRACT
Objectives Our aim was to assess the accuracy of a simpliﬁed fetal cardiac study, inclusive of four-chamber view (4CV)
and ventricular outﬂow tracts, performed during the 11–14week screening by well-trained obstetricians to detect
congenital heart diseases (CHDs).
Methods A transabdominal ultrasound was performed on 4820 singleton pregnant women at 11–14weeks to visualize
the visceral site, the 4CV, and the outﬂow tracts. Neonatal outcomes were recorded 6 and 12months after birth.
Results Among the 4820 patients reviewed, 790 were excluded because of loss at prenatal or postnatal follow-up (649
cases), or inability to obtain adequate ﬁrst-trimester sonographic cardiac evaluation (141 cases). Among the 4030
included cases, 32 CHD cases were detected (20 major and 12 minor); 18 of the major (90%) and ﬁve of the minor
(42%) were detected or suspected in the ﬁrst trimester, one major and six minor in the second trimester, and one
major and one minor only after birth.
Conclusions A simpliﬁed protocol is an effective tool to screen for CHD at 11–14weeks. © 2014 John Wiley & Sons, Ltd.
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INTRODUCTION
Congenital heart diseases (CHDs) are the most commonmalfor-
mations, with a prevalence ranging between 5 and 9/1000 live
births, and they are the leading cause of death due to malfor-
mation diseases in the ﬁrst year of life.1–3 Ultrasonography
is the gold standard for prenatal diagnosis of congenital
malformations,4–6 and fetal echocardiography performed in the
second and third trimester, also in high-risk populations, has a
60–100% sensitivity in diagnosing a major CHD7,8. The spread
of ﬁrst-trimester screening has allowed early diagnosis of various
congenital malformations,9 including CHD,3,10–13 given that
most cardiac malformations are already deﬁned at this stage.
The relationship between thick nuchal translucency (NT), altered
ductus venosus (DV), and tricuspid regurgitation (TR)14–17 with
CHD has heightened the interest towards early fetal cardiac
anomaly screening.
Early CHD detection has several advantages, namely reassuring
high-risk women with normal ultrasound screening and perfor-
ming early counseling in cases of pathological ﬁndings. Only few
ﬁrst-trimester fetal heart studies on low-risk populations have
been published in literature,12,13,20–23 also because of the difﬁculty
to perform a complete echocardiography in the ﬁrst trimester.24
The aim of our study was to evaluate a new simpliﬁed
approach to study the fetal hearth that can be used for
all pregnancies undergoing ﬁrst-trimester screening, visualizing
only the visceral site, the four-chamber view (4CV), and the
ventricular outﬂow tracts.
METHODS
This is a prospective study on an unselected population
referred to the Centre for Prenatal Diagnosis of Palermo, Italy,
between January 2009 and December 2011 for ﬁrst-trimester
screening of aneuploidies. The study included singleton
pregnancies with fetal crown–rump length between 48 and
84mm. Genetic screening was based on maternal age, levels
of maternal serum free beta human chorionic gonadotrophin
(hCG), and pregnancy-associated plasma protein A (PAPP-A)
on dried blood spot samples (DBS) (Life-Cycle, Perkin-
Elmer),25 NT measurement, and presence of fetal nasal bone
(NB), according to the Fetal Medicine Foundation (FMF)
criteria. All women underwent weight and height measurements
to calculate the body mass index (BMI) in kg/m2. A
transabdominal (TA) ultrasound screening was performed by
three experienced sonographers holding an FMF certiﬁcate of
competence for measurement of NT, NB, TR, and DV, using
Voluson E8 (GE Medical Systems, Zipf, Austria) ultrasound
machines with RAB 4–8D probes. Customized settings were used
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for ﬁrst-trimester fetal heart scan, minimizing ultrasound
exposure of the fetus, especially in the Doppler mode. In 202
patients, with substandard quality TA images, we performed an
additional transvaginal (TV) ultrasound examination using an
IC59HD probe.
During the test, in addition to measuring the NT, assessing
NB presence/absence, and observing several other fetal
anatomical structures according to the FMF protocol, instead
of a complete echocardiography, we followed a simpliﬁed
protocol to acquire speciﬁc information on the cardiac
morphology attempting to visualize the following:
• the visceral site and the position of the heart;
• the four chambers, their size, and the atrio-ventricular (AV) valves;
• the origin of the aorta from the left ventricle, the origin of the pulmonary
artery from the right ventricle, and the vessels crossing.
To increase accuracy and reduce the duration of the test, we
used color ﬂowmapping to visualize the transvalvular ﬂow and
its malfunctions, if any, and the appropriate ﬁlling of both
ventricles (Figure 1), as well as the ﬂow in the aortic and
pulmonary artery (Figures 2 and 3).
Cases reviewed in the ﬁrst trimester were classiﬁed as
apparently normal (3988), pathological (20), or suspicious (22).
The last group included cases where imaging, albeit suspicious,
failed to allow a precise deﬁnition or a clear-cut distinction
between physiology and pathology (e.g. apparent disproportion
between ventricles). In cases deemednormal, the fetal heart scan
required very limited additional time (never more than 10min).
A follow-up scan was performed at 20–22weeks to assess the
cardiac structure. In abnormal cases, we recommended fetal
karyotyping by villocentesis and scheduled a follow-up
2–3weeks later. In cases considered suspicious, the cardiac
evaluation was repeated at 15weeks of gestation.
Fetal cardiac defects were deﬁned as major, if they were
either lethal or required surgery or interventional cardiac
catheterization during the ﬁrst year of life in the newborn,
and minor, if they were generally asymptomatic. For the
purpose of this study, TR was not considered a CHD as it is
normally functional and transitory.
If the quality of the images was unsatisfactory, the patient
underwent a TV ultrasound examination. The clips and volumes
collected in each case considered pathological or suspicious
were subsequently reviewed by a pediatric cardiologist.
The parents were informed of the potential limitation of this
ultrasound screening, a technique still under evaluation, and of
the possibility of obtaining an uncertain picture that could cause
maternal anxiety while waiting for a more precise diagnosis.
Follow-up at 6 and 12months after birth was obtained on
the basis of the information provided with the clinical
examination by a neonatologist at birth, by the mothers, or
their gynecologists. We chose to seek information also from
the gynecologist because in Sicily, most of women are
treated during the pregnancy, delivery, and post-partum
by the same gynecologist, which has therefore reliable infor-
mation on the child’s health. In cases where the infant
underwent surgery, pertinent information was provided by
the pediatric surgeon.
Figure 1 Four-chamber view, transvalvular ﬂow at 12weeks
Figure 2 Left outﬂow tract at 12weeks
Figure 3 Pulmonary trunk ﬂow at 12weeks
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RESULTS
Of the patients examined during the study period (4820
singleton pregnancies), 649 were excluded because of lost to
second-trimester follow-up or at delivery. Additional 141 cases
were excluded because of failure to appropriately visualize the
cardiac morphology both with a TA and TV approach (41/686
or 6% cases at 11weeks, 58/1871 or 3.1% at 12weeks, and
42/1614 or 2.6% at 13weeks). The remaining population
included 4030 pregnancies, 3969 studied with a TA scan and
61 also with a TV scan. The average maternal age was 33 years
(range 16–43 year), weight was 65.7 kg (range 41–121 kg),
gestational age was 12.5weeks, and BMI 24.5 kg/m2 (range
17.5–43.3 kg/m2). Gestational age at the examination was 11
+weeks in 645 pregnancies (16%), 12+weeks in 1813 (45%),
and 13+weeks in 1572 (39%). Screening was considered
appropriate when it provided a satisfactory view of the four
chambers, the AV valves, and the origin and the crossing of
the large arteries. Color Doppler was used in a complementary
manner to visualize the chambers, the great vessels, and the
direction of ﬂows.
Following an insufﬁcient TA scan (202 cases), an additional
TV examination provided information on 61 women: at
11weeks in 27 (4%), at 12weeks in 21 (1.2%), and at 13weeks
in 13 cases (0.8%). The main factors hampering an appropriate
visualization of the cardiac structures were a high BMI and a
considerably early gestational age, as reported also by
previous studies.10–12 BMI was signiﬁcantly greater for women
in whom both TA and TV examinations were unsatisfactory
compared with those in whom it was successful (30.2 vs
24.5 kg/m2, p< 0.001). The mean crown–rump length was
65mm in successful cases versus 58mm in unsuccessful cases
(p< 0.001).
Among the 4030 fetuses included in the study there were
32 CHD cases (0.8%), 20 major and 12 minor (Table 1); 16
of the major and ﬁve of the minor cases were detected in
the ﬁrst trimester.
The most common major abnormality diagnosed was atrio-
ventricular septal defect (AVSD) (Figure 4), seven cases, and
hypoplastic left heart syndrome (HLHS) (Figure 5), four cases.
Women carrying a fetus with major CHD were offered villo-
centesis or, at a later stage, amniocentesis in cases ascertained
in the second trimester, to determine the fetal karyotype, but
four of them opted for voluntary termination of pregnancy
(TOP) without undergoing additional examinations (case 15
also showed fetal hydrops and case 21 an occipital ence-
phalocele). Of the 15 fetuses with major CHD undergoing fetal
karyotyping, nine (60%) presented an aneuploidy and the
pregnancy was terminated; two of them, cases 30 and 31 in
Table 1, presented a complex CHD difﬁcult to interpret, even
by a pediatric cardiologist. In the second trimester, a CHD
was conﬁrmed in all the remaining six fetuses although, in
one case, the pediatric cardiologist changed the diagnosis
made in the ﬁrst trimester (case 28) (Figure 6) from single
ventricle + truncus arteriosus to single ventricle + double outlet
right ventricle (DORV). Of the other four major CHDs, one
deemed normal in the ﬁrst trimester proved to be Tetralogy
of Fallot (TOF) at 20weeks; two classiﬁed as suspicious were
diagnosed as pathological at 15weeks (case 23 HLHS and case
32 DORV), whereas the last major CHD (aortic coarctation) was
detected only after birth. Six of the seven minor CHD not
detected in the ﬁrst trimester, ﬁve ventricular septal defect
(VSD) and one moderated chamber disproportion, were
identiﬁed in the second trimester, and one VSD was detected
only after birth. Twenty of the 22 suspicious cases proved to
be normal at 15 and 20weeks. There were no false positives
among the major CHD cases.
The clips and volumes collected for each fetus considered
pathological or suspicious were subsequently reviewed by a
pediatric cardiologist who agreed with all diagnoses except
that in case 28.
Of the 4030 fetuses included in our study, 205 (5.1%) had a
NT>95th percentile. The NT was higher than the 95th
percentile for gestational age in six of the 20 major CHD
(30%) and higher than the 99th percentile in ﬁve additional
cases, suggesting that an elevated NT can be an effective
marker of major CHD. Only in one of the 11 minor CHDs was
the NT abnormal (higher than the 99th percentile).
Aneuploidy screening results were positive in all seven cases
of Trisomy 21 and in four of the ﬁve Trisomy 18, and there were
no cases of Trisomy13.
No additional relevant CHDs were detected at follow-up 6
and 12months after birth.
DISCUSSION
Fetal echocardiography is usually performed in the second
trimester of pregnancy in patients with a high risk of carrying
a fetus affected by a CHD although the majority of infants with
a CHD have no previous risk factors.26 This study demonstrates
the possibility to use a simpliﬁed protocol to perform a CHD
screening during the ﬁrst-trimester TA ultrasound scan for
NT measurement.
There are several good reasons to attempt early CHD
detection: differently from other organs, for example, the
brain, at this stage, the fetal heart has almost fully developed;
compared with other malformations, CHD have a higher
prevalence27,28 and can be associated with chromosome
anomalies.
Over the years, a correlation has been documented, albeit
with modest sensitivity in euploid fetuses,14,19,30 between high
NT and CHD.30 In the same way, other ﬁrst-trimester markers
of aneuploidy such as TR and DV13–18 are associated with CHD.
This explains the growing interest in early study of cardiac
morphology, enhanced by the progress of ultrasound
technology and by the growing skill of operators performing
ﬁrst-trimester screening. In recent years, this has allowed to
assess the cardiac morphology in patients at low risk12,13,20
and high risk3–11 using a TA approach.
These tests require high-level ultrasound equipment, dedi-
cated settings, especially for color ﬂow mapping, essential for
correct visualization in cases of low echogenicity, and consi-
derable experience of operators studying fetal morphology.
Our data demonstrate how appropriately trained operators
can correctly identify most of the major CHD already in
the ﬁrst trimester. Our 11–14week simpliﬁed fetal cardiac
screening allowed us to detect (16) or suspect (2) 18 out of
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20 major CHD in the ﬁrst trimester, with a 90% sensibility
and a 99.5% speciﬁcity. The most frequent major CHD in
our series, as shown in Table 1, is represented by AVSD,
seven cases, and among these, three fetuses were affected by
Trisomy 21 and two by Trisomy 18, conﬁrming the strong
association between these anomalies and aneuploidies. In
four cases, we detected HLHS, but in three of these, the
parents decided to terminate the pregnancy declining an
invasive procedure. Among the minor CHDs, there were seven
VSDs, which are conﬁrmed as the most frequent congenital
heart malformation.1
The 4CV alone, relatively easy to obtain and repre-
senting the basis to assess, for example, the presence of
TR, allowed us, also using the color Doppler, to detect 15
of the 20 major CHD (75%). We believe that direct
observation of the cardiac morphology is more effective,
Table 1 Cases of congenital heart disease
# Cardiac defect Weeks First trimester Second trimester Outcome K NT Screening risk
Minor defects
1 VSD 12 VSD VSD OK NL 2.4 HIGH
2 VSD 13 VSD VSD OK NL 2.2 LOW
3 VSD 13 NL VSD OK NL 2.0 LOW
4 VSD 12 NL VSD OK NL 2.4 LOW
5 VSD 12 NL NL OK NL 1.5 LOW
6 VSD 12 NL VSD OK NL 1.6 LOW
7 VSD 13 NL VSD OK NL 1.9 LOW
8 VSD 13 NL VSD OK NL 2.0 LOW
9 LV< RV 11 LV< RV LV< RV IUD 20weeks NL 10a HIGH
10 LV< RV 12 NL LV< RV OK NL 1.6 LOW
11 RA> LA 13 RA> LA RA> LA OK NL 1.9 LOW
12 Rt Ao Arch 13 Rt Ao Arch Rt Ao Arch OK NL 2.2 LOW
Major defects
13 AVSD 12 AVSD TOP T18 4.5a HIGH
14 AVSD 12 AVSD TOP T21 8.0a HIGH
15 AVSD 12 AVSD TOP 9.3a HIGH
16 AVSD 12 AVSD TOP T21 3.3b HIGH
17 AVSD 12 AVSD TOP T21 5a HIGH
18 AVSD 12 AVSD AVSD AAS OK 2.9b LOW
19 AVSD 12 AVSD TOP T18 3.1b HIGH
20 TGA 13 TGA TGA AAS OK 2.0 LOW
21 HLHS 12 HLHS TOP 1.2 LOW
22 HLHS 13 HLHS TOP 1.8 LOW
23 HLHS 13 SUSP. HLHS DAS OK 2.5 LOW
24 HLHS 13 HLHS TOP 3.2b LOW
25 TOF 12 NL TOF AAS OK 1.5 LOW
26 PA stenosis 13 PA stenosis PA stenosis DAS OK 2.5 HIGH
27 TR atresia 13 TR atresia TR atresia TOP T21 2.9b HIGH
28 Single ventricle +DORV 12 Single Ventr. + Truncus Single Ventr. +DORV TOP T18 3.1b LOW
29 Ao Coartation 13 NL NL AAS 2.2 LOW
30 Complex CHD 12 ?? TOP T18 3.7a HIGH
31 Complex CHD 13 ?? TOP T13 2.5 LOW
32 DORV 13 SUSP. DORV AAS OK 2.4 LOW
K, karyotype; AAS, alive after surgery; Ao coartation, coartation of the aorta; AVSD, atrioventricular septal defect; IUD, intra-uterine death; LA, left atrium; LOW, low risk; LV, left
ventricle; NL, normal; NT, nuchal translucency; RA, right atrium; Rt Ao Arch, right aortic arch; RV, right ventricle; SUSP., suspicious; TGA, transposition of the great arteries; TOF,
Tetralogy of Fallot; TOP, termination of pregnancy; TRUNCUS., truncus arteriosus; VSD, ventricular septal defect.
aNT at >99th percentile.
bNT at >95th percentile.
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at least for the structures more easily visualized using our
suggested simpliﬁed protocol, than searching for indirect
CHD markers such as DV and TR. In addition, we believe
that a CHD screening following this simpliﬁed protocol is
by no means technically more complex than studying the
VD or TR currently used as risk markers for CHD and
aneuploidies.
The major CHDs are already present, and detectable in most
cases, in the ﬁrst trimester although between the ﬁrst and
second trimesters, some cases present different evolutionary
features. For example, complete AV canal defects can be
easily detected if appropriately investigated, others such as
the Tetralogy of Fallot are more insidious, and others such
as aortic coartation are difﬁcult to diagnose at an early
stage because of their history and natural evolution. Other
scenarios, such as chamber disproportions, may be more
difﬁcult to interpret – they can evolve overtime for better
or for worse – and call for additional investigation in terms
of reference values and clinical signiﬁcance. On the other
hand, second-trimester fetal morphology screening still
stands as essential.
As in several published works,3–13,19 a limitation of this study
is the unavailability of post-mortem examination in cases in
which the patients decided for TOP. The echocardiography
and postnatal surgery, when required, did however conﬁrm
the diagnosis in the other cases.
A major CHD is frequently associated to chromosomal
anomalies, as reported by other studies,2–10,12 with a very low
incidence of false positives. In our study, nine of 16 fetuses
affected by a major CHD (60%) were aneuploidic, and in the
absence of fetal karyotyping, we cannot rule out other cases
of chromosomal anomalies in the four cases of TOP. On the
other hand, out of the 13 fetuses with a chromosomal anomaly
included in our sample, nine (69%) had a major CHD. Given
that the fetuses with a major CHD and a normal karyotype in
our group were only seven (we are unaware of the karyotype
of four fetuses with major CHD as the pregnancies were
terminated), detecting a major CHD in the ﬁrst trimester
proves to be an effective marker of chromosomal disorders
with a 69% sensibility and a 99.8% speciﬁcity.
CONCLUSION
An obstetrician with good experience in second-trimester
fetal heart screening can distinguish most, but not all, of
the normal ﬁndings from the abnormal ones, visualizing
the 4CV and ventricular outﬂows in the ﬁrst trimester
of pregnancy.
Figure 4 Color Doppler image demonstrating a complete atrioven-
tricular septal defect
Figure 5 Color Doppler image demonstrating single ﬂow through the
tricuspid valve (hypoplastic left heart syndrome)
Figure 6 Single ventricle + double outlet right ventricle (case 28):
color Doppler image demonstrating the single ventricle and mitral
regurgitation (arrow)
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An important goal of the ﬁrst-trimester cardiac scan is to
differentiate normal cases from those that require subsequent
investigation and the assistance of a pediatric cardiologist.
Early CHD detection in the ﬁrst trimester will allow to
reassure mothers with healthy fetuses, to perform a short-to-
medium-term follow-up in suspicious cases, to provide
appropriate counseling in the presence of cardiac anomalies,
allowing the option of TOP at an earlier stage and the possi-
bility to detect associated chromosomal disorders.
A fetal cardiac scan using a simpliﬁed protocol such as the
one we describe can become an essential part of ﬁrst-trimester
ultrasound screening of all fetuses.
WHAT’S ALREADY KNOWN ABOUT THIS TOPIC?
• First-trimester screening allowes early diagnosis of various
congenital malformations, including congenital heart disease.
• Few ﬁrst-trimester fetal heart studies on low-risk populations are
published because of the difﬁculty to perform a complete
echocardiography in the ﬁrst trimester.
WHAT DOES THIS STUDY ADD?
• This study demonstrates how possible it is to detect most cardiac
abnormalities by using a simpliﬁed protocol to screen for congenital
heart disease during the ﬁrst-trimester scan.
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